Relugolix: A new kid on the block among gonadotrophin-releasing hormone antagonists

Androgen-deprivation therapy (ADT) is the cornerstone of metastatic prostate cancer treatment. ADT can be achieved through surgical castration, or it may be induced either by gonadotrophin-releasing hormone (GnRH) agonists or GnRH antagonists. GnRH antagonists provide a more rapid castration alongsi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fragkoulis, Charalampos, Glykas, Ioannis, Dellis, Athanasios, Mitsogiannis, Iraklis, Papatsoris, Athanasios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648026/
https://www.ncbi.nlm.nih.gov/pubmed/34881062
http://dx.doi.org/10.1080/2090598X.2021.1994231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648026/
https://www.ncbi.nlm.nih.gov/pubmed/34881062
http://dx.doi.org/10.1080/2090598X.2021.1994231

Ejemplares similares